| Characteristics and Outcomes of Coronavirus Infection in Children: The Role of Viral Factors and an Immunocompromised State |
51 |
| Epidemiology and Clinical Features of Human Coronaviruses in the Pediatric Population |
23 |
| A Multicenter Consortium to Define the Epidemiology and Outcomes of Inpatient Respiratory Viral Infections in Pediatric Hematopoietic Stem Cell Transplant Recipients |
13 |
| Noninfectious Manifestations and Complications of Chronic Granulomatous Disease |
13 |
| The Burden of Congenital Cytomegalovirus Infection: A Prospective Cohort Study of 20 000 Infants in Finland |
11 |
| Refractory Pseudomonas Bacteremia in a 2-Year-Old Sterilized by Bacteriophage Therapy |
11 |
| Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art |
10 |
| BCG Vaccination at Birth and Rate of Hospitalization for Infection Until 15 Months of Age in Danish Children: A Randomized Clinical Multicenter Trial |
10 |
| Results of a Targeted Screening Program for Congenital Cytomegalovirus Infection in Infants Who Fail Newborn Hearing Screening |
10 |
| Procalcitonin Accurately Identifies Hospitalized Children With Low Risk of Bacterial Community-Acquired Pneumonia |
10 |
| Defining the Role of Novel beta-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms |
9 |
| Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS): A Quality Improvement Collaborative |
9 |
| Chronic Granulomatous Disease: Epidemiology, Pathophysiology, and Genetic Basis of Disease |
9 |
| Considerations in the Diagnosis of Chronic Granulomatous Disease |
8 |
| Human Immunodeficiency Virus (HIV)-Antibody Repertoire Estimates Reservoir Size and Time of Antiretroviral Therapy Initiation in Virally Suppressed Perinatally HIV-Infected Children |
8 |
| US Emergency Department Visits for Adverse Drug Events From Antibiotics in Children, 2011-2015 |
8 |
| Prediction of Resistance to Intravenous Immunoglobulin in Children With Kawasaki Disease |
8 |
| Evaluation of a Live Attenuated Human Metapneumovirus Vaccine in Adults and Children |
8 |
| Antibiotic Stewardship in the Neonatal Intensive Care Unit: Effects of an Automatic 48-Hour Antibiotic Stop Order on Antibiotic Use |
7 |
| Severe Parechovirus 3 Infections in Young Infants-Kansas and Missouri, 2014 |
7 |
| Patterns of Growth, Body Composition, and Lipid Profiles in a South African Cohort of Human Immunodeficiency Virus-Infected and Uninfected Children: A Cross-Sectional Study |
7 |
| Neonatal and Pediatric Candidemia: Results From Population- Based Active Laboratory Surveillance in Four US Locations, 2009-2015 |
7 |
| National Estimates of Reductions in Acute Gastroenteritis-Related Hospitalizations and Associated Costs in US Children After Implementation of Rotavirus Vaccines |
7 |
| Risk Factors for Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review |
6 |
| Expanding Existing Antimicrobial Stewardship Programs in Pediatrics: What Comes Next |
6 |
| Performance of Surveillance Case Definitions in Detecting Respiratory Syncytial Virus Infection Among Young Children Hospitalized With Severe Respiratory Illness-South Africa, 2009-2014 |
6 |
| High Rates of Prescribing Antimicrobials for Prophylaxis in Children and Neonates: Results From the Antibiotic Resistance and Prescribing in European Children Point Prevalence Survey |
6 |
| Congenital Babesiosis After Maternal Infection With Borrelia burgdorferi and Babesia microti |
6 |
| Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infections in Pediatric Hematopoietic Stem Cell Transplant Recipients |
6 |
| Change in Bacterial Causes of Community-Acquired Parapneumonic Effusion and Pleural Empyema in Children 6 Years After 13-Valent Pneumococcal Conjugate Vaccine Implementation |
5 |
| Incidence and Outcomes of Infections Caused by Multidrug-Resistant Enterobacteriaceae in Children, 2007-2015 |
5 |
| Use of Internet Search Data to Monitor Rotavirus Vaccine Impact in the United States, United Kingdom, and Mexico |
5 |
| Increasing Clindamycin and Trimethoprim-Sulfamethoxazole Resistance in Pediatric Staphylococcus aureus Infections |
5 |
| A Multicenter Consortium to Define the Epidemiology and Outcomes of Pediatric Solid Organ Transplant Recipients With Inpatient Respiratory Virus Infection |
5 |
| Capsule-Negative emm Types Are an Increasing Cause of Pediatric Group A Streptococcal Infections at a Large Pediatric Hospital in Texas |
5 |
| Individualized Empiric Vancomycin Dosing in Neonates Using a Model-Based Approach |
5 |
| Serologic Detection of Antibodies Targeting the Leukocidin LukAB Strongly Predicts Staphylococcus aureus in Children With Invasive Infection |
5 |
| Intervention and Acceptance Rates Support Handshake-Stewardship Strategy |
5 |
| Clinical and Laboratory Predictors of Shiga Toxin-Producing Escherichia coli Infection in Children With Bloody Diarrhea |
5 |
| Association of Previous Measles Infection With Markers of Acute Infectious Disease Among 9-to 59-Month-Old Children in the Democratic Republic of the Congo |
5 |
| Prevention of Infectious Complications in Patients With Chronic Granulomatous Disease |
4 |
| Future of Care for Patients With Chronic Granulomatous Disease: Gene Therapy and Targeted Molecular Medicine |
4 |
| Trichosporonosis in Pediatric Patients With a Hematologic Disorder |
4 |
| Clinical Features and Outcomes of Immunocompromised Children Hospitalized With Laboratory-Confirmed Influenza in the United States, 2011-2015 |
4 |
| Intestinal Carriage of Third-Generation Cephalosporin-Resistant and Extended-Spectrum beta-Lactamase-Producing Enterobacteriaceae in Healthy US Children |
4 |
| Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies Beyond Severe Combined Immunodeficiency |
4 |
| What Parents Think About the Risks and Benefits of Antibiotics for Their Child's Acute Respiratory Tract Infection |
4 |
| The 112-Year Odyssey of Pertussis and Pertussis Vaccines-Mistakes Made and Implications for the Future |
4 |
| Factors Associated With Pneumonia Severity in Children: A Systematic Review |
4 |
| Evaluation of Intravenous Posaconazole Dosing and Pharmacokinetic Target Attainment in Pediatric Patients |
4 |
